Blog
Are Machine Learning Models the Future of More Accurate and Precise Safety Signal Monitoring?
Explore the results of 4 different machine learning models and how they can change the current safety monitoring landscape.
Decades of Protection: The Enduring Legacy of the Quadrivalent HPV Vaccine
The quadrivalent human papillomavirus (qHPV) vaccine has demonstrated remarkable durability in preventing HPV-related diseases, even over a decade after administration. Long-term follow-up (LTFU) studies across diverse populations reaffirm its efficacy, safety, and...
HER-2 Phase II Breast Cancer Study: Everything You Need to Know
Welcome to our deep dive on the ongoing breast cancer vaccine study, formally known as the "Multicenter Phase II Study of Vaccines to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer". This study is slated to conclude in 2026, and has the main...
Dengue Diffusion: “Effective Dengue Control is Going to Require Multi-Layered Efforts”
Stated plainly by Adam Waickman, an accomplished immunologist at SUNY Upstate Medical University in Syracuse, slowing the dengue virus epidemic is going to take the international collaboration of drug development experts as well as every tool at their disposal. With...
Pharmacovigilance Development: A Global Challenge
Pharmacovigilance is an incredibly essential component of monitoring patient safety. One of the largest responsibilities of pharmacovigilance professionals is to observe adverse drug reactions (ADRs) and act in the best interest of the public. While the drug...
Is PV Conducted in All Breast Cancer Treatments?
Breast cancer has been one of the largest global threats to women's health for decades, with the American Cancer Society estimating nearly 297,790 new cases in U.S. women during 2023 alone. Recent developments in clinical research have highlighted the possibility...